Flow Traders U.S.’s Translational Development Acquisition Corp Units TDACU Stock Holding History

Flow Traders U.S.’s Portfolio TDACU Stock Details TDACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$132K	Sell	11,659 -2,428	-17%	-$29.9K	0.01%	933
2026 Q1	$148K	Hold	14,087	–	–	﹤0.01%	930
2025 Q4	$148K	Sell	14,087 -1,700	-11%	-$17.7K	﹤0.01%	831
2025 Q3	$162K	Buy	15,787 +1,559	+11%	+$16.3K	0.01%	876
2025 Q2	$146K	Buy	14,228 +3,854	+37%	+$39.5K	0.01%	860
2025 Q1	$105K	Sell	10,374 -12,126	-54%	-$122K	﹤0.01%	844
2024 Q4	$225K	Buy	+22,500	New	+$225K	0.01%	852

Other funds holding TDACU

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Flow Traders U.S.'s TDACU Position: Q2 2026 in Review

Flow Traders U.S. reduced its Translational Development Acquisition Corp Units (TDACU) stake by 17% in Q2 2026, selling an estimated $29.9K and leaving 11,659 shares worth $132K. The position accounts for 0.01% of the portfolio, ranked #933.

Flow Traders U.S. first reported a position in TDACU in Q4 2024 and has held it in 7 quarters since. The position peaked at $225K in Q4 2024. 3 funds tracked by Wall St. Rank hold TDACU as of Q2 2026.

Flow Traders U.S. held 11,659 shares of Translational Development Acquisition Corp Units worth $132K as of Q2 2026.
Flow Traders U.S. sold 2,428 Translational Development Acquisition Corp Units shares in Q2 2026, an estimated $29.9K.
Translational Development Acquisition Corp Units made up 0.01% of Flow Traders U.S.'s portfolio in Q2 2026, its #933 holding.
Flow Traders U.S. first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and has held it in 7 quarters since.
Flow Traders U.S.'s Translational Development Acquisition Corp Units position peaked at $225K in Q4 2024.
3 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q2 2026.

Based on Flow Traders U.S.'s 13F filing for Q2 2026, filed 14 Aug 2026.